More than 700 CyberKnife® and TomoTherapy® Systems Have Treated More Than Half a Million Patients Worldwide SUNNYVALE, Calif., November 25, 2013 – Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in global adoption of its CyberKnife® and TomoTherapy® Systems. Accuray has expanded its installed base to more than 700 systems worldwide which have been used to treat more than […]
UCLA Researchers Evaluate Long-term Outcomes of More than 1,000 Patients from Multiple Institutions SUNNYVALE, Calif., November 7, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles (UCLA). The first […]
Accuray Incorporated- One company with two great technologies who develops personalized, leading-edge treatment solutions that help cancer patients live longer, better lives. SOURCE: Accuray
Data Supports Growing Use of CyberKnife® SBRT for Prostate Cancer SUNNYVALE, Calif., October 3, 2013 and ASTRO 2013 (Atlanta)– Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting in Atlanta, September 22 – 25, 2013 continue to reinforce evidence of clinical and quality of life benefits for […]
Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013 World’s Largest Annual Gathering of the Radiation Oncology Community Provides Multiple Opportunities to Learn about the CyberKnife® M6™ Series and the TomoTherapy® H™ Series Systems SUNNYVALE, Calif., September 22, 2013 and ASTRO 2013 (Atlanta)– Accuray Incorporated (Nasdaq: ARAY) announced today […]
SUNNYVALE, Calif., September 3, 2013— Accuray Incorporated (Nasdaq: ARAY), announced today that Derek Bertocci has resigned as Senior Vice President and Chief Financial Officer of the company effective September 2, 2013. Today, Accuray has appointed Gregory Lichtwardt, executive vice president, chief financial officer, effective immediately. Mr. Bertocci is anticipated to continue in a consulting role […]
New Tulsa Cancer Institute Offers Accuray’s Latest Cancer Fighting Technology SUNNYVALE, Calif., June 25, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today that the Tulsa Cancer Institute is the first U.S. center to treat a patient with Accuray’s TomoHDA™ System, the latest and most advanced innovation in the TomoTherapy® product lineage designed to treat the full spectrum of cancer […]
Lancaster General Health Unveils Leading Robotic Radiosurgery System SUNNYVALE, Calif., June 13, 2013 – Accuray Incorporated (Nasdaq: ARAY) announced today that Lancaster General Health in Pennsylvania is the first U.S. center to treat a patient with the CyberKnife® M6™ System, the most advanced robotic radiosurgery system in the world and the latest generation of the […]
Advanced Radiation Treatment Now Available to Cancer Patients in France SUNNYVALE, Calif., June 5, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today the first patient has been treated with its new TomoHDA™ System at Centre Oscar Lambret in Lille, France. Building upon the proven TomoTherapy® Hi-Art® and TomoHD™ technologies, the TomoHDA System is a fully-integrated […]
Updated ASTRO Model Policy Endorses Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer SUNNYVALE, Calif., May 21, 2013 – Accuray Incorporated (Nasdaq: ARAY), announced today the publication of study results involving hundreds of prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System, the most widely used form of prostate stereotactic body radiation therapy (SBRT). […]